How It Works:
Erlotinib belongs to a class of medications called tyrosine kinase inhibitors. It works by preventing the activity of a protein called epidermal growth factor, and thereby stops the growth and spread of cancer cells.
dry skin, cough, fatigue, alopecia, nausea, folliculitis, Infection, liver function test abnormalities, abdominal pain, anorexia, , dyspepsia, vomiting, conjunctivitis, depression, skin fissures., acne, rigor, pruritus, diarrhea, stomatitis, neuropathy, rash, paronychia, dyspnea, serious lung disease, headache, gastrointestinal bleeding, weight changes, flatulence
Erlotinib is used to treat metastatic non-small cell lung cancer, as first line treatment, maintenance treatment, or after failure of one prior chemotherapy. It is also used to treat locally advanced, unresectable (which cannot be removed by surgery), or metastatic (cancer which has spread) pancreatic cancer in combination with another drug called gemcitabine.
Frequently Ask Questions:
Q. Is erlotinib safe during pregnancy?Erlotinib may harm the fetus hence not recommended for use during pregnancy. Please follow your doctor's advice regarding its use.
Q. Is erlotinib safe during lactation?Erlotinib may not be safe for a breast-fed infant. It should only be used if no other alternative drug is available. Please follow your doctor's advice regarding its use.
Q. Is erlotinib cytotoxic, chemotherapeutic drug, biologic or monoclonal antibody?Erlotinib is not a cytotoxic, chemotherapy drug, or monoclonal antibody. Erlotinib is a biologic tyrosine kinase inhibitor.
Q. Is erlotinib FDA approved?Yes, erlotinib is approved by FDA.
Q. Does erlotinib cause neutropenia?Yes, erlotinib can cause neutropenia.
Q. How long does erlotinib work?A single dose of erlotinib works for around 36 hours.